Company Will Donate Hemp Cannabidiol (CBD) Products to Eligible Participants at 2nd Annual “Run4Hope 5K and Fun Run” That Will Raise Funds for CDKL5 Seizure Research
SAN DIEGO, Aug. 27, 2013 (GLOBE NEWSWIRE) — Medical Marijuana Inc. (OTC Pink: MJNA) is pleased to inform shareholders and the general public that HempMedsPX – a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana Inc. – will be the top sponsor of “Run4Hope,” a fundraiser for CDKL5 seizure research. Run4Hope will take place on September 7, 2013 in Coppell, Texas.
CDKL5 is a rare genetic seizure disorder that has no known cure. Symptoms usually present themselves in the first few months of a child’s life. Most CDKL5 children cannot walk or talk, and are often confined to a wheelchair. Many are unable to feed themselves and suffer from additional medical issues related to their physical impairment.
“Dr. Gupta’s report on medical cannabis gave cannabidiol the kind of mainstream attention that it truly deserves,” said Charles Vest, Director of Communications for HempMedsPX. “For those families who saw Dr. Sanjay Gupta’s special on CNN and want to try high-CBD cannabis oil, but have been afraid of legal or physical consequences of medical marijuana, HempMedsPX has a legal, hemp-based alternative.
“As a father myself, I know how frightening medical marijuana may seem at first. What makes our CBD-rich cannabis oil different is that it is made from hemp seed and stalk, which means it’s 100% legal to consume in all fifty states and over forty countries. That also means that it’s non-psychoactive. What we’re offering is natural, lab-produced and independently tested CBD-rich hemp oil. Nothing more.”
The “Run 4 Hope” fundraiser is expected to draw over 200 participants, many of which have family members who suffer from epilepsy, seizure disorders, or CDKL5. HempMedsPX will be on-site at Run 4 Hope to distribute free samples of Real Scientific Hemp Oil (RSHO), which is 98%+/- cannabidiol (CBD) by concentration (18% by volume), to qualified families. RSHO is similar to the marijuana-based cannabis oil featured on Dr. Gupta’s documentary, WEED, but unlike marijuana-based cannabis oils, RSHO is federally legal to possess and consume. There is no “high” or “stoned” effect from RSHO. Medical Marijuana Inc., CannaVest Corp., and HempMedsPX do not make any medical claims on any of their products, but offer federally-legal, whole-food sources of CBD-rich hemp oil to consumers.
“We are very excited to have HempMedsPX as our top sponsor. They have come through for us in a very big way,” said Penny Howard, co-founder of Hope4Harper. “This event will raise the awareness of this debilitating disorder in our community and raise significant funds for more research by Dr. Frances Jensen, Chair of the Department of Neurology at the University of Pennsylvania.”
Penny also added, “I am certain there are thousands of families in Texas that do not know of this amazing product and its availability. I personally am adding this oil to Harper’s diet and I already see a difference.”
The Second Annual “Run 4 Hope 5K and Fun Run” will be held at Andy Brown Park East in Coppell, Texas on September 7, 2013. For more information about the event or to donate to the cause, please visit Hope4Harper.com.
According to the US government, every product derived from cannabis is categorized as marijuana – including hemp. We, therefore, use the word “marijuana” as an all-encompassing term to cover cannabis, medical marijuana, marijuana and hemp. We believe that “cannabis” should be the standard term used for all medical products; as the industry matures, we will be phasing out the words “medical marijuana” and “marijuana” from the company’s vocabulary.
HempMedsPX is the master distributor and contracted marketing company for the CannaVest Corp. (OTC: CANV) and Medical Marijuana, Inc. (OTC Pink: MJNA) portfolio of products, including their revolutionary hemp-based cannabidiol (CBD) products. HempMedsPX offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. In addition to handling sales and distribution, HempMedsPX is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com
About CannaVest Corp.
CannaVest Corp. is in the business of investing and developing hemp-based cannabinoid companies. CannaVest Corp. also develops, produces, markets and sells end-consumer products to the nutraceutical industry containing the hemp plant extract, cannabidiol (CBD). Additionally, the company resells – to third parties – raw product acquired by CannaVest Corp. pursuant to the company’s supply relationships in Europe. CannaVest Corp. seeks to take advantage of an emerging worldwide trend to re-energize the production of industrial hemp and to foster its many uses for consumers. Cannabinoids (cannabidiol/CBD) are natural constituents of the hemp plant and CBD is derived from hemp stalk and seed. Additional information is available from OTCMarkets.com or by visiting CannaVest.com.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. and CannaVest Corp. dos not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The companies do grow, sell and distribute hemp-based products and is involved with federally legal distribution of medical marijuana-based products within certain international markets. We use the following names for informational purposes only, all of which refer to the legal industrial hemp plant: cannabis, canipa, kanipa, kanna, canna, kanabis, marijuana, medical marijuana, hemp, and industrial hemp.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Investor relations contact:
Stuart T. Smith